← Back to headlines
United Therapeutics Stock Surges on Positive Tyvaso Trial Results
United Therapeutics shares have surged following positive results from trials of its drug Tyvaso, which is being developed for the treatment of idiopathic pulmonary fibrosis.
30 Mar, 15:41 — 30 Mar, 15:41
Sources
Showing 1 of 1 sources
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
56m ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
12h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
14h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
23h ago